10-Q: Panamera Holdings Reports Increased Revenue but Continues to Face Losses in Q1 2025

Sentiment:

Quarterly Report


Panamera Holdings Corporation's Q1 2025 shows increased revenue driven by raw material sales, but the company still reports a net loss and expresses doubt about its ability to continue as a going concern.

Capital raiseThe company intends to fund operations through debt and/or equity financing arrangements.Management intends to raise additional funds through public or private placement offerings.
Worse than expectedThe company's net loss increased compared to the same period last year.The company's operating expenses increased significantly.The company has a substantial working capital deficiency.The company expresses substantial doubt about its ability to continue as a going concern.

Summary

  • Panamera Holdings Corporation reported a net loss of $72,568 for the three months ended October 31, 2024, compared to a net loss of $62,992 for the same period in 2023.
  • Total revenues increased to $43,568, driven by $35,663 in related party revenue, compared to no revenue in the prior year.
  • Operating expenses increased to $114,219 from $64,911 in the prior year, primarily due to stock-based compensation and general and administrative expenses.
  • The company's discontinued healthcare consulting operations generated $2,010 in income during the three months ended October 31, 2023, but were divested in March 2024.
  • As of October 31, 2024, the company had a working capital deficiency of $275,787 and expresses substantial doubt about its ability to continue as a going concern.
  • The company intends to fund operations through debt and/or equity financing arrangements and related party advances.
  • The company is pursuing business opportunities in environmental services, emerging innovative technologies, and individual health choices.
  • A Letter of Intent was signed to purchase 51% of a Canadian corporation for $10,000,000, but it has not been executed as of the filing date.

Sentiment

Score: 3

Explanation: The document presents a mixed picture with increased revenue offset by significant losses, a working capital deficiency, and concerns about the company's ability to continue as a going concern. The identified material weaknesses in internal controls further contribute to a negative sentiment.

Positives

  • Revenue increased significantly to $43,568 due to raw material sales, including sales to a related party.
  • The company is actively pursuing new business opportunities in environmental services, emerging technologies, and health choices.
  • The company is seeking additional funding through public or private placement offerings.

Negatives

  • The company reported a net loss of $72,568 for the quarter.
  • Operating expenses increased significantly to $114,219.
  • The company has a substantial working capital deficiency of $275,787.
  • There is substantial doubt about the company's ability to continue as a going concern.
  • Disclosure controls and procedures were deemed ineffective due to material weaknesses related to related party transactions and segregation of duties.

Risks

  • The company's ability to continue as a going concern is dependent on obtaining additional financing.
  • The company's disclosure controls and procedures are not effective due to material weaknesses.
  • The company faces competition from entities with greater financial, technical, and managerial capabilities.
  • The Letter of Intent to purchase a Canadian corporation may not be executed.
  • The company is materially dependent on a third party to provide accounting consulting services.

Future Outlook

The company intends to fund operations through debt and/or equity financing arrangements and related party advances and is pursuing business opportunities in environmental services, emerging innovative technologies, and individual health choices. The company is also seeking a business combination with an operating company.

Management Comments

  • Prior management intended to offer management and consulting services to healthcare organizations, but current management have redirected our efforts now to pursuing business opportunities including but not limited to the environmental services industry, emerging innovative technologies and individual health choices led by innovation with integration.

Industry Context

The company's shift in focus to environmental services, emerging technologies, and health choices reflects a broader trend of companies seeking growth in innovative and high-potential sectors. However, the company's limited capital and competition from larger entities pose significant challenges.

Comparison to Industry Standards

  • Given the company's early stage and shift in business focus, direct comparisons to industry standards are difficult.
  • Many small companies in the environmental services and technology sectors face similar challenges in securing funding and establishing market presence.
  • The company's reliance on related party transactions and the identified material weaknesses in internal controls are areas of concern compared to industry best practices.

Related Party Transactions

  • During the three months ended October 31, 2024 and 2023, related parties financed $5,598 and $0 for operation expenses and repaid related parties loan of $1,600 and $19,102, respectively.
  • As of October 31, 2024, and July 31, 2024, the Company was obliged for unsecure, non-interest-bearing demand loans to three related parties, with balances of $80,146 and $76,148, respectively.
  • During the three months ended October 31, 2024, and 2023, the Company recognized $1,878 and $919 interest on related party balances and imputed in additional paid-in-capital, respectively.
  • During the three months ended October 31,2024, and 2023 the Company generated revenues of $35,663 and $0 from sales of material to a company controlled by a related party.

Stakeholder Impact

  • Shareholders face significant risk due to the company's financial instability and going concern uncertainty.
  • Employees may be affected by potential cost-cutting measures or restructuring.
  • Creditors face increased risk of non-payment due to the company's financial difficulties.

Next Steps

  • The company intends to pursue debt and/or equity financing arrangements.
  • The company will continue to seek and analyze potential business opportunities and/or combinations.
  • The company needs to address the material weaknesses in its disclosure controls and procedures.

Key Dates

DateDescription
May 20, 2014Panamera Holdings Corporation incorporated in Nevada
October 21, 2021Company changed name from Panamera Healthcare Corporation to Panamera Holdings Corporation and increased authorized common stock.
March 1, 2022Company entered into a consulting agreement with First DP Ventures, LP.
June 2, 2023Board of Directors approved the creation of three wholly owned subsidiaries.
July 20, 2023Three wholly owned subsidiaries were registered in the State of Texas.
March 29, 2024Consulting agreement with First DP Ventures, LP was terminated.
June 17, 2024Company entered into an engagement agreement with an officer and granted stock options.
July 1, 2024Company entered into an operating lease for office space.
August 8, 2024Company entered into a binding Purchase Agreement for Membership Interests with AusTex Aggregates LLC.
October 1, 2024Parties closed the Purchase Agreement with AusTex Aggregates LLC.
October 31, 2024End of the quarterly period.
November 1, 2024An individual purchased 100,000 shares of newly issued restricted common stock.
December 4, 2024Company signed a Letter of Intent with a Canadian corporation.
January 13, 2025The Company's Annual Report on Form 10-K, for the year ended July 31, 2024, as filed with the SEC.
January 17, 2025Company and AusTex Aggregates LLC agreed to discontinue the Purchase Agreement for Membership Interests.
January 31, 20252,750,000 shares of restricted common stock were cancelled.
February 12, 202551,510,000 shares of common stock outstanding.
February 14, 2025Date of report filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.